Study S001272

The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)Informed Consent Form (PDF)

Registration

Registration: NCT03645408
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: TERMINATED
Enrollment: 8
Start: 2019-05-02
Primary completion: 2021-07-01
Lead sponsor: Boston Medical Center
Conditions: Alcohol Use Disorder
Interventions: DRUG:Exenatide; OTHER:Sham injection
Results posted: TRUE
Individual participant data sharing: NO
Secondary identifiers: NIH:R21AA027332-01

Registered primary outcomes

Alcohol Consumption [2 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.